Patients with IBD are at risk of the same vaccine-preventable illnesses as the general population. However, the characteristics of IBD and the immunosuppressive agents prescribed to treat it can lead to low response rates to vaccinations in these patients. Gisbert and Chaparro provide practical advice on vaccination strategies for clinicians who diagnose and treat patients with IBD.
- Javier P. Gisbert
- María Chaparro
